Imiquimod treatment associated with a reduction in new skin cancer formation.
Czarnecki
C
C
Czarnecki
D
D
Carroll
S
S
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000368:Aged; D000634:Aminoquinolines / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D006801:Humans; D000077271:Imiquimod; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy* / Q000601:surgery; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000601:surgery
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod